Friday, June 19, 2026

AI Wellness Revolution: Insights from SK Intellix’s NAMUHX Meetup and Future Hackathon Plans

SK Intellix hosted the 1st NAMUHX Meetup to expand its AI wellness ecosystem, connecting developers and discussing future innovations.

Vice Minister Of Unification And Foreign Strategy Director To Hold North Korea Consultations This Month

North Korea showcases Kim Jong Un with family to promote unity, emphasizing a socialist big family image amid succession speculation.

Remembering the Cheonan Incident: 16 Years of Sacrifice and Truth Amidst North Korean Denial

Students honor 55 heroes of the West Sea Defense as the People Power Party commemorates the Cheonan sinking's anniversary and condemns distortion.

Tag: glucagon

MetaVia to Present DA-1726 Phase 1 Obesity Trial Data at EASL Congress 2026

Dong-A ST's Meta via will present DA-1726, a dual-action obesity treatment, at the EASL Congress 2026, showcasing promising clinical trial results.

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

Top News

- Our Sponsors Ad -

Follow us